Document

2014 Interim Guidance on Patent Subject Matter Eligibility

The United States Patent and Trademark Office (USPTO or Office) has prepared interim guidance (2014 Interim Guidance on Patent Subject Matter Eligibility, called "Interim Eligib...

Department of Commerce
United States Patent and Trademark Office
  1. 37 CFR Part 1
  2. [Docket No. PTO-P-2014-0058]

AGENCY:

United States Patent and Trademark Office, Commerce.

( printed page 74619)

ACTION:

Examination guidance; request for comments.

SUMMARY:

The United States Patent and Trademark Office (USPTO or Office) has prepared interim guidance (2014 Interim Guidance on Patent Subject Matter Eligibility, called “Interim Eligibility Guidance”) for use by USPTO personnel in determining subject matter eligibility under 35 U.S.C. 101 in view of recent decisions by the U.S. Supreme Court (Supreme Court). This Interim Eligibility Guidance supplements the June 25, 2014, Preliminary Examination Instructions in view of the Supreme Court decision in Alice Corp. (June 2014 Preliminary Instructions) and supersedes the March 4, 2014, Procedure For Subject Matter Eligibility Analysis Of Claims Reciting Or Involving Laws Of Nature/Natural Principles, Natural Phenomena, And/Or Natural Products (March 2014 Procedure) issued in view of the Supreme Court decisions in Myriad and Mayo. The USPTO is seeking public comment on this Interim Eligibility Guidance along with additional suggestions on claim examples for explanatory example sets.

DATES:

Effective Date: This Interim Eligibility Guidance is effective on December 16, 2014. This Interim Eligibility Guidance applies to all applications filed before, on or after December 16, 2014.

Comment Deadline Date: To be ensured of consideration, written comments must be received on or before March 16, 2015.

ADDRESSES:

Comments on this Interim Eligibility Guidance must be sent by electronic mail message over the Internet addressed to: . Electronic comments submitted in plain text are preferred, but also may be submitted in ADOBE® portable document format or MICROSOFT WORD® format. The comments will be available for viewing via the Office's Internet Web site ( www.uspto.gov). Because comments will be made available for public inspection, information that the submitter does not desire to make public, such as an address or phone number, should not be included in the comments.

FOR FURTHER INFORMATION CONTACT:

Raul Tamayo, Senior Legal Advisor, Office of Patent Legal Administration, by telephone at 571-272-7728, or Michael Cygan, Senior Legal Advisor, Office of Patent Legal Administration, by telephone at 571-272-7700.

SUPPLEMENTARY INFORMATION:

Section 2106 of the Manual of Patent Examining Procedure (MPEP) sets forth guidance for use by USPTO personnel in determining subject matter eligibility under 35 U.S.C. 101. See MPEP 2106 (9th ed. 2014). The USPTO has prepared this Interim Eligibility Guidance for use by USPTO personnel in determining subject matter eligibility under 35 U.S.C. 101 in view of recent decisions by the Supreme Court. The following Interim Eligibility Guidance on patent subject matter eligibility under 35 U.S.C. 101 supplements the June 25, 2014, Preliminary Examination Instructions in view of the Supreme Court Decision in Alice Corporation Pty. Ltd. v. CLS Bank International, et al.[1] (June 2014 Preliminary Instructions) and supersedes the March 4, 2014, Procedure For Subject Matter Eligibility Analysis Of Claims Reciting Or Involving Laws Of Nature/Natural Principles, Natural Phenomena, And/Or Natural Products (March 2014 Procedure) [2] issued in view of the Supreme Court decisions in Association for Molecular Pathology v. Myriad Genetics, Inc.[3] and Mayo Collaborative Services v. Prometheus Laboratories Inc.[4] Implementation of examination guidance on eligibility will be an iterative process continuing with periodic supplements based on developments in patent subject matter eligibility jurisprudence [5] and public feedback.

The USPTO is seeking written comments on this guidance, as well as additional suggestions for claim examples to use for examiner training. Further, the USPTO plans to hold a public forum in mid-January 2015 in order to discuss the guidance and next steps and to receive additional oral input. When the date and location are finalized, notice of the forum will be provided on the Office's Internet Web site ( www.uspto.gov).

This Interim Eligibility Guidance does not constitute substantive rulemaking and does not have the force and effect of law. This Interim Eligibility Guidance sets out the Office's interpretation of the subject matter eligibility requirements of 35 U.S.C. 101 in view of recent decisions by the Supreme Court and the U.S. Court of Appeals for the Federal Circuit (Federal Circuit), and advises the public and Office personnel on how these court decisions impact the provisions of MPEP 2105, 2106 and 2106.01. This Interim Eligibility Guidance has been developed as a matter of internal Office management and is not intended to create any right or benefit, substantive or procedural, enforceable by any party against the Office. Rejections will continue to be based upon the substantive law, and it is these rejections that are appealable. Failure of Office personnel to follow this Interim Eligibility Guidance is not, in itself, a proper basis for either an appeal or a petition.

This Interim Eligibility Guidance offers a comprehensive view of subject matter eligibility in line with Alice Corp, Myriad,Mayo, and the related body of case law, and is responsive to the public comments received pertaining to the March 2014 Procedure and the June 2014 Preliminary Instructions ( see the Notice of Forum on the Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena, and Natural Products, 79 FR 21736 (Apr. 17, 2014) and the Request for Comments and Extension of Comment Period on Examination Instruction and Guidance Pertaining to Patent-Eligible Subject Matter, 79 FR 36786 (June 30, 2014)). In conjunction with this Interim Eligibility Guidance, a set of explanatory examples relating to nature-based products is being released to replace the prior examples issued with the March 2014 Procedure and the related training. The explanatory examples relating to nature-based products address themes raised in the public comments and adopt many suggestions from the comments. Additional explanatory example sets relating to claims that do and do not amount to significantly more than a judicial exception are being developed and will be issued at a future date, taking into account suggestions already received from the public comments, ( printed page 74620) future public comments, and any further judicial developments.

The June 2014 Preliminary Instructions superseded MPEP sections 2106(II)(A) and 2106(II)(B). MPEP 2105 is also superseded by this Interim Eligibility Guidance to the extent that it suggests that “mere human intervention” necessarily results in eligible subject matter. MPEP 2106.01 is additionally now superseded with this interim guidance. Examiners should continue to follow the MPEP for all other examination instructions. The following sections pertain to examining for patent subject matter eligibility with details on determining what applicant invented and making a rejection under 35 U.S.C. 101 and should be reviewed closely as they are not duplicated in this Interim Eligibility Guidance:

2103(I): Determine What Applicant Has Invented and Is Seeking to Patent

2103(II): Conduct a Thorough Search of the Prior Art

2103(III): Determine Whether the Claimed Invention Complies With 35 U.S.C. 101

2103(IV): Evaluate Application for Compliance With 35 U.S.C. 112

2103(V): Determine Whether the Claimed Invention Complies With 35 U.S.C. 102 and 103

2103(VI): Clearly Communicate Findings, Conclusions, and Their Bases

Footnotes

1.   Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 573 U.S. __, 134 S. Ct. 2347 (2014).

Back to Citation

2.  This analysis differs from the March 2014 Procedure in certain respects. Note, for example, the test for determining whether a claim is directed to a “product of nature” exception is separated from the analysis of whether the claim includes significantly more than the exception. Also, the application of the overall analysis is based on claims directed to judicial exceptions (defined as claims reciting the exception, i.e., set forth or described), rather than claims merely “involving” an exception. For instance, process claims that merely use a nature-based product are not necessarily subject to an analysis for markedly different characteristics. Additionally, the markedly different analysis focuses on characteristics that can include a product's structure, function, and/or other properties as compared to its naturally occurring counterpart in its natural state.

Back to Citation

3.   Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. __, 133 S. Ct. 2107 (2013).

Back to Citation

4.   Mayo Collaborative Serv. v. Prometheus Labs., Inc., 566 U.S. __, 132 S. Ct. 1289 (2012).

Back to Citation

5.  The Court of Appeals for the Federal Circuit has a number of pending appeals that could result in further refinements to the eligibility guidance, including for example, University of Utah Research Foundation v. Ambry Genetics Corp. (In re BRCA1- & BRCA2-Based Hereditary Cancer Test Patent Litigation), No. 14-1361 (Fed. Cir. filed Mar. 18, 2014), and Ariosa Diagnostics, Inc. v. Sequenom, Inc., No. 14-1139 (Fed. Cir. filed Dec. 4, 2013).

Back to Citation

6.  To the extent that MPEP 2105 suggests that mere “human intervention” necessarily results in eligible subject matter, it is superseded by this Interim Eligibility Guidance. As explained herein, if human intervention has failed to confer markedly different characteristics on a product derived from nature, that product is a judicial exception (a product of nature exception). See generally Myriad; In re Roslin Inst. (Edinburgh), 750 F.3d. 1333 (Fed. Cir. 2014).

Back to Citation

7.   Alice Corp., 134 S. Ct. at 2355.

Back to Citation

8.   Mayo, 132 S. Ct. at 1301 (“[E]ven though rewarding with patents those who discover new laws of nature and the like might well encourage their discovery, those laws and principles, considered generally, are ‘the basic tools of scientific and technological work.’ And so there is a danger that the grant of patents that tie up their use will inhibit future innovation premised upon them, a danger that becomes acute when a patented process amounts to no more than an instruction to ‘apply the natural law,’ or otherwise forecloses more future invention than the underlying discovery could reasonably justify” (quoting Gottschalk v. Benson, 409 U.S. 63, 67 (1972)).

Back to Citation

9.  An invention is not rendered ineligible for patent simply because it involves an abstract concept. Applications of such concepts “to a new and useful end,” remain eligible for patent protection. Alice Corp., 134 S.Ct. at 2354 (quoting Benson, 409 U.S. at 67).

Back to Citation

10.   O'Reilly v. Morse, 56 U.S. 62 (1853).

Back to Citation

11.   Tilghman v. Proctor, 102 U.S. 707 (1881).

Back to Citation

12.   Alice Corp., 134 S. Ct. at 2355-56.

Back to Citation

13.   Bilski v. Kappos, 561 U.S. 593 (2010).

Back to Citation

14.   buySAFE, Inc. v. Google, Inc., ___ F.3d ___, 112 USPQ2d 1093 (Fed. Cir. 2014).

Back to Citation

15.   Ultramercial, LLC v. Hulu, LLC and WildTangent, ___ F.3d ___, 112 USPQ2d 1750 (Fed. Cir. 2014).

Back to Citation

16.   Dealertrack Inc. v. Huber, 674 F.3d 1315 (Fed. Cir. 2012).

Back to Citation

17.   SmartGene, Inc. v. Advanced Biological Labs., SA, 555 Fed. Appx. 950 (Fed. Cir. 2014) (nonprecedential).

Back to Citation

18.   Cyberfone Sys. v. CNN Interactive Grp., 558 Fed. Appx. 988 (Fed. Cir. 2014) (nonprecedential).

Back to Citation

19.   Digitech Image Tech., LLC v. Electronics for Imaging, Inc., 758 F.3d 1344 (Fed. Cir. 2014).

Back to Citation

20.   Planet Bingo, LLC v. VKGS LLC, ___ Fed. Appx. ___ (Fed. Cir. 2014) (nonprecedential).

Back to Citation

21.   Diamond v. Diehr, 450 U.S. 175 (1981).

Back to Citation

22.   Parker v. Flook, 437 U.S. 584 (1978).

Back to Citation

23.   Mackay Radio & Tel. Co. v. Radio Corp. of Am., 306 U.S. 86 (1939).

Back to Citation

24.   Benson, 409 U.S. at 63.

Back to Citation

25.   Myriad, 133 S. Ct. at 2111.

Back to Citation

26.   Alice Corp., 134 S. Ct. at 2360.

Back to Citation

27.  This revised analysis represents a change from prior guidance, because now changes in functional characteristics and other non-structural properties can evidence markedly different characteristics, whereas in the March 2014 Procedure only structural changes were sufficient to show a marked difference.

Back to Citation

28.  To show a marked difference, a characteristic must be changed as compared to nature, and cannot be an inherent or innate characteristic of the naturally occurring counterpart. Funk Bros. Seed Co. v. Kalo Inoculant Co., 333 U.S. 127, 130 (1948) (“[The inventor did] not create a state of inhibition or of non-inhibition in the bacteria. Their qualities are the work of nature. Those qualities are of course not patentable.”); In re Marden, 47 F.2d 958 (CCPA 1931) (eligibility of a claim to ductile vanadium held ineligible, because the “ductility or malleability of vanadium is . . . one of its inherent characteristics and not a characteristic given to it by virtue of a new combination with other materials or which characteristic is brought about by some chemical reaction or agency which changes its inherent characteristics”). Further, a difference in a characteristic that came about or was produced independently of any effort or influence by applicant cannot show a marked difference. Roslin, 750 F.3d at 1338 (Because “any phenotypic differences came about or were produced `quite independently of any effort of the patentee' ” and were “uninfluenced by Roslin's efforts”, they “do not confer eligibility on their claimed subject matter” (quoting Funk Bros.)).

Back to Citation

29.   See, e.g.,Funk Bros., 333 U.S. at 130-31 (properties and functions of bacteria such as a state of inhibition or non-inhibition and the ability to infect leguminous plants); Diamond v. Chakrabarty, 447 U.S. 303, 310 (1980) (genetically modified bacterium's ability to degrade hydrocarbons); In re King, 107 F.2d 618 (CCPA 1939) (the ability of vitamin C to prevent and treat scurvy); Myriad, 133 S. Ct. at 2111, 2116-17 (the protein-encoding information of a nucleic acid).

Back to Citation

30.   See, e.g.,Parke-Davis & Co. v. H.K. Mulford Co., 189 F. 95, 103-04 (S.D.N.Y. 1911) (the alkalinity of a chemical compound); Marden, 47 F.2d at 958 (the ductility or malleability of metals); Funk Bros., 333 U.S. at 130 (“The qualities of these bacteria, like the heat of the sun, electricity, or the qualities of metals, are part of the store-house of knowledge of all men. They are manifestations of laws of nature, free to all men and reserved exclusively to none.”).

Back to Citation

31.   See, e.g.,Roslin, 750 F.3d at 1338 (phenotype, including functional and structural characteristics, e.g., the shape, size, color, and behavior of an organism).

Back to Citation

32.   See, e.g.,Chakrabarty, 447 U.S. at 305 and n.1 (the physical presence of plasmids in a bacterial cell); Parke-Davis, 189 F. at 100, 103 (claimed chemical was a “nonsalt” and a “crystalline substance”); Myriad, 133 S. Ct. at 2116, 2119 (nucleotide sequence of DNA); Roslin, 750 F.3d at 1338-39 (the genetic makeup (genotype) of a cell or organism).

Back to Citation

33.   Alice Corp., 134 S. Ct. at 2357.

Back to Citation

34.   Alice Corp., 134 S. Ct. at 2359 (citing Diehr, 450 U.S. at 177-78) (a mathematical formula applied in a specific rubber molding process).

Back to Citation

35.   Id., at 2359.

Back to Citation

36.   Bilski, 130 S. Ct. at 3227 (“The Court's precedents establish that the machine-or-transformation test is a useful and important clue, an investigative tool, for determining whether some claimed inventions are processes under § 101.”).

Back to Citation

37.   Diehr, 450 U.S. at 184 (“That respondents' claims [to a specific rubber molding process] involve the transformation of an article, in this case raw, uncured synthetic rubber, into a different state or thing cannot be disputed.”). See also Benson, 409 U.S. at 70 (“Transformation and reduction of an article `to a different state or thing' is the clue to the patentability of a process claim that does not include particular machines. So it is that a patent in the process of `manufacturing fat acids and glycerine from fatty bodies by the action of water at a high temperature and pressure' was sustained in Tilghman, 102 U.S. at 721”).

Back to Citation

38.   Mayo, 132 S. Ct. at 1299, 1302 (claim ineligible because the recited “instructions add nothing specific to the laws of nature other than what is well-understood, routine, conventional activity, previously engaged in by those in the field,” which was “[u]nlike, say, a typical patent on a new drug or a new way of using an existing drug”).

Back to Citation

39.   Alice Corp., 134 S. Ct. at 2360 (noting that none of the hardware recited “offers a meaningful limitation beyond generally linking `the use of the [method] to a particular technological environment,' that is, implementation via computers” (citing Bilski, 561 U.S. at 610, 611)).

Back to Citation

40.   Id. at 2358 (simply implementing a mathematical principle on a physical machine, namely a computer (citing Mayo, 132 S. Ct. at 1301)).

Back to Citation

41.   Id. at 2359 (using a computer to obtain data, adjust account balances, and issue automated instructions); Mayo, 132 S. Ct. at 1300 (telling a doctor to measure metabolite levels in the blood using any known process).

Back to Citation

42.   Mayo, 132 S. Ct. at 1297-98 (measuring metabolites of a drug administered to a patient); Flook, 437 U.S. at 589-90 (1978) (adjusting an alarm limit variable to a figure computed according to a mathematical formula).

Back to Citation

43.   Mayo, 132 S. Ct. at 1300-01 (citing Bilski, 130 S. Ct. 3223-24) (limiting hedging to use in commodities and energy markets); Flook, 437 U.S. at 589-90.

Back to Citation

44.   Chakrabarty, 447 U.S. at 303.

Back to Citation

45.  In Alice Corp., the parties stipulated that the method was performed by a computer, despite the lack of a computer recitation in the representative method claim.

Back to Citation

46.   SiRF Tech. v. ITC, 601 F.3d 1319 (Fed. Cir. 2010).

Back to Citation

47.   Research Corp. Tech. v. Microsoft Corp., 627 F.3d 859 (Fed. Cir. 2010).

Back to Citation

[FR Doc. 2014-29414 Filed 12-15-14; 8:45 am]

BILLING CODE 3510-16-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

79 FR 74618

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“2014 Interim Guidance on Patent Subject Matter Eligibility,” thefederalregister.org (December 16, 2014), https://thefederalregister.org/documents/2014-29414/2014-interim-guidance-on-patent-subject-matter-eligibility.